Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

NCT02381886

Conditions
Adenocarcinoma, Advanced Malignancies That Harbor IDHR132 Mutations, Astrocytoma, +19 more
Locations
  • Dana Farber Cancer Institute SC (1) Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center- New York Presbyterian Onc Dept. New York, United States
  • Columbia University Medical Center New York, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

NCT04562389

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • UAB Division of Hematology/Oncology Birmingham, Alabama, United States
  • UCLA - Satellite Site Beverly Hills, California, United States
  • City of Hope Duarte, California, United States
  • UCLA - Satellite Site Encino, California, United States
View all 166 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

NCT04547049

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
Locations
  • Xiangya Hospital Central South University Changsha, China
  • Xinqiao Hospital, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University Chongqing, China
  • The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, China
  • Zhejiang Provincial People's Hospital Hangzhou, China
View Trial Details
Active, Not Recruiting

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

NCT04684108

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Affiliated Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hostipal Beijing, Beijing Municipality, China
  • Shenzhen Second People's Hospital Shenzhen, Guangzhou, China
View all 14 locations
View Trial Details
Active, Not Recruiting

Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy

NCT03993912

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Chru Jean Minjoz Besançon, France
  • Ch Blois Simone Veil Blois, France
  • Ch Fleyriat Bourg-en-Bresse, France
  • Chru Brest Site Hopital Morvan Brest, France
View all 23 locations
View Trial Details

Related conditions